Becton Dickinson Net Profit Margin 2012-2026 | BDX
Current and historical net profit margin for Becton Dickinson (BDX) from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue. Becton Dickinson net profit margin for the three months ending March 31, 2026 was .
| Becton Dickinson Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-03-31 | $21.37B | $1.14B | 5.33% |
| 2025-12-31 | $21.92B | $1.76B | 8.01% |
| 2025-09-30 | $21.84B | $1.68B | 7.68% |
| 2025-06-30 | $21.39B | $1.59B | 7.41% |
| 2025-03-31 | $20.87B | $1.50B | 7.18% |
| 2024-12-31 | $20.64B | $1.73B | 8.37% |
| 2024-09-30 | $20.18B | $1.71B | 8.45% |
| 2024-06-30 | $19.83B | $1.41B | 7.13% |
| 2024-03-31 | $19.72B | $1.32B | 6.68% |
| 2023-12-31 | $19.49B | $1.22B | 6.25% |
| 2023-09-30 | $19.37B | $1.42B | 7.35% |
| 2023-06-30 | $19.05B | $1.58B | 8.30% |
| 2023-03-31 | $18.81B | $1.53B | 8.12% |
| 2022-12-31 | $18.74B | $1.52B | 8.11% |
| 2022-09-30 | $18.87B | $1.69B | 8.95% |
| 2022-06-30 | $18.41B | $1.67B | 9.05% |
| 2022-03-31 | $18.38B | $1.83B | 9.96% |
| 2021-12-31 | $18.53B | $1.68B | 9.04% |
| 2021-09-30 | $19.13B | $2.00B | 10.46% |
| 2021-06-30 | $18.57B | $1.87B | 10.04% |
| 2021-03-31 | $17.82B | $1.64B | 9.20% |
| 2020-12-31 | $17.16B | $1.51B | 8.79% |
| 2020-09-30 | $16.07B | $0.77B | 4.77% |
| 2020-06-30 | $16.92B | $0.79B | 4.65% |
| 2020-03-31 | $17.41B | $0.92B | 5.30% |
| 2019-12-31 | $17.36B | $0.76B | 4.38% |
| 2019-09-30 | $17.29B | $1.08B | 6.26% |
| 2019-06-30 | $17.11B | $0.78B | 4.58% |
| 2019-03-31 | $17.04B | $0.93B | 5.44% |
| 2018-12-31 | $17.06B | $0.90B | 5.25% |
| 2018-09-30 | $15.98B | $0.16B | 0.99% |
| 2018-06-30 | $14.75B | $0.62B | 4.21% |
| 2018-03-31 | $13.50B | $-0.10B | -0.74% |
| 2017-12-31 | $12.25B | $0.29B | 2.40% |
| 2017-09-30 | $12.09B | $1.03B | 8.52% |
| 2017-06-30 | $12.16B | $0.76B | 6.25% |
| 2017-03-31 | $12.32B | $1.32B | 10.67% |
| 2016-12-31 | $12.42B | $1.31B | 10.54% |
| 2016-09-30 | $12.48B | $0.98B | 7.82% |
| 2016-06-30 | $12.31B | $1.14B | 9.24% |
| 2016-03-31 | $12.23B | $0.81B | 6.62% |
| 2015-12-31 | $11.22B | $0.69B | 6.13% |
| 2015-09-30 | $10.28B | $0.70B | 6.76% |
| 2015-06-30 | $9.42B | $0.82B | 8.65% |
| 2015-03-31 | $8.46B | $1.08B | 12.75% |
| 2014-12-31 | $8.48B | $1.15B | 13.56% |
| 2014-09-30 | $8.45B | $1.19B | 14.03% |
| 2014-06-30 | $8.35B | $0.97B | 11.67% |
| 2014-03-31 | $8.24B | $0.95B | 11.53% |
| 2013-12-31 | $8.17B | $0.94B | 11.49% |
| 2013-09-30 | $8.05B | $1.29B | 16.05% |
| 2013-06-30 | $7.92B | $1.49B | 18.84% |
| 2013-03-31 | $7.85B | $1.52B | 19.33% |
| 2012-12-31 | $7.78B | $1.53B | 19.70% |
| 2012-09-30 | $7.71B | $1.17B | 15.18% |
| 2012-06-30 | $7.61B | $1.18B | 15.52% |
| 2012-03-31 | $7.58B | $1.20B | 15.79% |
| 2011-12-31 | $7.57B | $1.22B | 16.08% |
| 2011-09-30 | $7.58B | $1.27B | 16.76% |
| 2011-06-30 | $7.34B | $1.37B | 18.64% |
| 2011-03-31 | $7.22B | $1.33B | 18.45% |
| 2010-12-31 | $7.10B | $1.32B | 18.57% |
| 2010-09-30 | $7.12B | $1.32B | 18.50% |
| 2010-06-30 | $7.22B | $1.24B | 17.14% |
| 2010-03-31 | $7.21B | $1.27B | 17.64% |
| 2009-12-31 | $7.14B | $1.24B | 17.30% |
| 2009-09-30 | $6.99B | $1.23B | 17.62% |
| 2009-06-30 | $6.86B | $1.20B | 17.44% |
| 2009-03-31 | $6.89B | $1.15B | 16.72% |
| 2008-12-31 | $6.91B | $1.17B | 16.89% |
| 2008-09-30 | $6.90B | $1.13B | 16.34% |
| 2008-06-30 | $6.88B | $1.11B | 16.07% |
| 2008-03-31 | $6.66B | $1.05B | 15.82% |
| 2007-12-31 | $6.49B | $1.02B | 15.72% |
| 2007-09-30 | $6.28B | $0.89B | 14.18% |
| 2007-06-30 | $6.17B | $0.81B | 13.04% |
| 2007-03-31 | $6.00B | $0.77B | 12.77% |
| 2006-12-31 | $5.85B | $0.68B | 11.58% |
| 2006-09-30 | $5.74B | $0.75B | 13.11% |
| 2006-06-30 | $5.58B | $0.73B | 13.03% |
| 2006-03-31 | $5.51B | $0.71B | 12.92% |
| 2005-12-31 | $5.45B | $0.75B | 13.68% |
| 2005-09-30 | $5.34B | $0.72B | 13.52% |
| 2005-06-30 | $5.29B | $0.64B | 12.10% |
| 2005-03-31 | $5.15B | $0.56B | 10.85% |
| 2004-12-31 | $5.04B | $0.54B | 10.64% |
| 2004-09-30 | $4.94B | $0.47B | 9.44% |
| 2004-06-30 | $4.79B | $0.56B | 11.68% |
| 2004-03-31 | $4.72B | $0.58B | 12.32% |
| 2003-12-31 | $4.60B | $0.56B | 12.14% |
| 2003-09-30 | $4.46B | $0.55B | 12.26% |
| 2003-06-30 | $4.36B | $0.52B | 11.87% |
| 2003-03-31 | $4.19B | $0.51B | 12.11% |
| 2002-12-31 | $4.07B | $0.49B | 12.15% |
| 2002-09-30 | $3.96B | $0.48B | 12.12% |
| 2002-06-30 | $3.94B | $0.48B | 12.20% |
| 2002-03-31 | $3.89B | $0.48B | 12.32% |
| 2001-12-31 | $3.83B | $0.46B | 12.12% |
| 2001-09-30 | $3.75B | $0.40B | 10.70% |
| 2001-06-30 | $3.68B | $0.35B | 9.60% |
| 2001-03-31 | $3.65B | $0.35B | 9.56% |
| 2000-12-31 | $3.62B | $0.35B | 9.77% |
| 2000-09-30 | $3.62B | $0.39B | 10.83% |
| 2000-06-30 | $3.60B | $0.38B | 10.67% |
| 2000-03-31 | $3.56B | $0.30B | 8.51% |
| 1999-12-31 | $3.51B | $0.27B | 7.81% |
| 1999-09-30 | $3.42B | $0.28B | 8.05% |
| 1999-06-30 | $3.36B | $0.29B | 8.60% |
| 1999-03-31 | $3.32B | $0.25B | 7.41% |
| 1998-12-31 | $3.18B | $0.25B | 7.79% |
| 1998-09-30 | $3.12B | $0.24B | 7.57% |
| 1998-06-30 | $3.02B | $0.24B | 7.77% |
| 1998-03-31 | $2.90B | $0.32B | 10.88% |
| 1997-12-31 | $2.86B | $0.31B | 10.71% |
| 1997-09-30 | $2.81B | $0.30B | 10.67% |
| 1997-06-30 | $2.79B | $0.30B | 10.67% |
| 1997-03-31 | $2.78B | $0.31B | 10.98% |
| 1996-12-31 | $2.79B | $0.30B | 10.66% |
| 1996-09-30 | $2.77B | $0.28B | 10.25% |
| 1996-06-30 | $2.76B | $0.28B | 10.29% |
| 1996-03-31 | $2.77B | $0.27B | 9.88% |
| 1995-12-31 | $2.76B | $0.26B | 9.57% |
| 1995-09-30 | $2.71B | $0.25B | 9.33% |
| 1995-06-30 | $2.71B | $0.25B | 9.31% |
| 1995-03-31 | $2.66B | $0.24B | 9.15% |
| 1994-12-31 | $2.60B | $0.24B | 9.04% |
| 1994-09-30 | $2.56B | $0.23B | 8.87% |
| 1994-06-30 | $2.51B | $0.22B | 8.65% |
| 1994-03-31 | $2.48B | $0.22B | 8.71% |
| 1993-12-31 | $2.46B | $0.22B | 8.74% |
| 1993-09-30 | $2.47B | $0.07B | 2.88% |
| 1993-06-30 | $2.48B | $0.07B | 2.70% |
| 1993-03-31 | $2.45B | $0.07B | 2.70% |
| 1992-12-31 | $2.43B | $0.06B | 2.56% |
| 1992-09-30 | $2.37B | $0.20B | 8.54% |
| 1992-06-30 | $2.26B | $0.19B | 8.49% |
| 1992-03-31 | $2.23B | $0.19B | 8.31% |
| 1991-12-31 | $2.19B | $0.18B | 8.31% |
| 1991-09-30 | $2.17B | $0.19B | 8.70% |
| 1991-06-30 | $2.16B | $0.19B | 8.75% |
| 1991-03-31 | $2.10B | $0.19B | 8.89% |
| 1990-12-31 | $2.07B | $0.18B | 8.90% |
| 1990-09-30 | $2.01B | $0.18B | 9.09% |
| 1990-06-30 | $1.95B | $0.18B | 8.99% |
| 1990-03-31 | $1.89B | $0.21B | 11.30% |
| 1989-12-31 | $1.84B | $0.21B | 11.61% |
| 1989-09-30 | $1.81B | $0.21B | 11.75% |
| 1989-06-30 | $1.68B | $0.21B | 12.72% |
| 1989-03-31 | $1.72B | $0.17B | 9.96% |
| 1988-12-31 | $1.72B | $0.17B | 9.60% |
| 1988-09-30 | $1.71B | $0.16B | 9.42% |
| 1988-06-30 | $1.80B | $0.15B | 8.30% |
| 1988-03-31 | $1.71B | $0.14B | 8.36% |
| 1987-12-31 | $1.64B | $0.14B | 8.56% |
| 1987-09-30 | $1.58B | $0.15B | 9.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |